Ikris PharmaApr 8, 20212 min readFDA Granted Approval of Selinexor Triplet for Refractory/Relapsed Multiple MyelomaOn December 18'th, 2020, the FDA granted approval to selinexor along with bortezomib and dexamethasone in order to treat adult patients...